NCT01478893View on ClinicalTrials.gov

Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Smoking Cessation
Interventions
BIOLOGICAL

SEL-068

Sub-cutaneous injection, multiple dose

BIOLOGICAL

Saline

Sub-cutaneous injection, multiple dose

Trial Locations (1)

Unknown

SGS LSS Clinical Pharmacology Unit, Antwerp

All Listed Sponsors
lead

Selecta Biosciences, Inc.

INDUSTRY

NCT01478893 - Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers | Biotech Hunter | Biotech Hunter